{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:09:20Z","timestamp":1793041760464,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270615"],"award-info":[{"award-number":["32270615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970144"],"award-info":[{"award-number":["81970144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68509-x","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:06:19Z","timestamp":1768928779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid leukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"Lingling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaodong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8099-6327","authenticated-orcid":false,"given":"Junxia","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-0003","authenticated-orcid":false,"given":"Fudi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"68509_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. Y. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"68509_CR2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu, H., Guo, P., Xie, X., Wang, Y. & Chen, G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J. Cell. Mol. Med. 21, 648\u2013657 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"68509_CR3","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu, Y. et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol. Cell. Oncol. 2, e1054549 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"68509_CR4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830\u2013849 (2019).","journal-title":"Cancer Cell"},{"key":"68509_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"68509_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou, Y. et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12, 34 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"68509_CR7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"68509_CR8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell, B. R., Jiang, X. & Gu, W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 30, 478\u2013490 (2020).","journal-title":"Trends Cell Biol."},{"key":"68509_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"68509_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"68509_CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang, Y. P. et al. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab. 33, 174\u2013189.e177 (2021).","journal-title":"Cell Metab."},{"key":"68509_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie, Y. et al. Ferroptosis: process and function. Cell Death Differ. 23, 369\u2013379 (2016).","journal-title":"Cell Death Differ."},{"key":"68509_CR13","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. GPX4-independent ferroptosis-a new strategy in disease\u2019s therapy. Cell Death Discov. 8, 434 (2022).","journal-title":"Cell Death Discov."},{"key":"68509_CR14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao, C. et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593, 586\u2013590 (2021).","journal-title":"Nature"},{"key":"68509_CR15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"68509_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft, V. A. N. et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent. Sci. 6, 41\u201353 (2020).","journal-title":"ACS Cent. Sci."},{"key":"68509_CR17","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia, B. et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J. Clin. Investig. 128, 3341\u20133355 (2018).","journal-title":"J. Clin. Investig."},{"key":"68509_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"68509_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"68509_CR20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal, and inner cell mass specification. Nature 466, 1129\u20131133 (2010).","journal-title":"Nature"},{"key":"68509_CR21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300\u20131303 (2011).","journal-title":"Science"},{"key":"68509_CR22","doi-asserted-by":"crossref","unstructured":"Zhang, X. C., Zhang, Y., Wang, C. F. & Wang, X. TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. Signal Transduct Tar 8, 297 (2023).","DOI":"10.1038\/s41392-023-01537-x"},{"key":"68509_CR23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.14348\/molcells.2015.0294","volume":"38","author":"JA Han","year":"2015","unstructured":"Han, J. A., An, J. & Ko, M. Functions of TET proteins in hematopoietic transformation. Mol. Cells 38, 925\u2013935 (2015).","journal-title":"Mol. Cells"},{"key":"68509_CR24","first-page":"517","volume":"18","author":"XJ Wu","year":"2017","unstructured":"Wu, X. J. & Zhang, Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18, 517\u2013534 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"68509_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10066","volume":"473","author":"K Williams","year":"2011","unstructured":"Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343\u2013348 (2011).","journal-title":"Nature"},{"key":"68509_CR26","volume":"8","author":"X Jiang","year":"2017","unstructured":"Jiang, X. et al. Targeted inhibition of STAT\/TET1 axis as a therapeutic strategy for acute myeloid leukemia. Nat. Commun. 8, 2099 (2017).","journal-title":"Nat. Commun."},{"key":"68509_CR27","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1073\/pnas.1310656110","volume":"110","author":"H Huang","year":"2013","unstructured":"Huang, H. et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc. Natl. Acad. Sci. USA 110, 11994\u201311999 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68509_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.2020008986","volume":"138","author":"L Jiang","year":"2021","unstructured":"Jiang, L. et al. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood 138, 689\u2013705 (2021).","journal-title":"Blood"},{"key":"68509_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457 (2017).","journal-title":"Nature"},{"key":"68509_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton, J. K. et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol. 16, 497\u2013506 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"68509_CR31","doi-asserted-by":"crossref","first-page":"103438","DOI":"10.1016\/j.redox.2024.103438","volume":"78","author":"X Wang","year":"2024","unstructured":"Wang, X., Shi, W., Li, M., Xin, Y. & Jiang, X. RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition. Redox Biol. 78, 103438 (2024).","journal-title":"Redox Biol."},{"key":"68509_CR32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","volume":"9","author":"X Sui","year":"2018","unstructured":"Sui, X. et al. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer. Front. Pharmacol. 9, 1371 (2018).","journal-title":"Front. Pharmacol."},{"key":"68509_CR33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00018-022-04396-x","volume":"79","author":"K Joshi","year":"2022","unstructured":"Joshi, K., Liu, S., Breslin, S. J. P. & Zhang, J. Mechanisms that regulate the activities of TET proteins. Cell. Mol. Life Sci. CMLS 79, 363 (2022).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"68509_CR34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"68509_CR35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm1443","volume":"12","author":"M Yan","year":"2006","unstructured":"Yan, M. et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 12, 945\u2013949 (2006).","journal-title":"Nat. Med."},{"key":"68509_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acsmedchemlett.8b00474","volume":"10","author":"GNL Chua","year":"2019","unstructured":"Chua, G. N. L. et al. Cytosine-based TET enzyme inhibitors. ACS Med. Chem. Lett. 10, 180\u2013185 (2019).","journal-title":"ACS Med. Chem. Lett."},{"key":"68509_CR37","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess, H. et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37, 5435\u20135450 (2018).","journal-title":"Oncogene"},{"key":"68509_CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1074\/jbc.RA119.009548","volume":"295","author":"H Nishizawa","year":"2020","unstructured":"Nishizawa, H. et al. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J. Biol. Chem. 295, 69\u201382 (2020).","journal-title":"J. Biol. Chem."},{"key":"68509_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"68509_CR40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/cr.2010.156","volume":"20","author":"H Zhang","year":"2010","unstructured":"Zhang, H. et al. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 20, 1390\u20131393 (2010).","journal-title":"Cell Res."},{"key":"68509_CR41","first-page":"41","volume":"7","author":"D Tang","year":"2024","unstructured":"Tang, D. & Kang, R. NFE2L2 and ferroptosis resistance in cancer therapy. Cancer Drug Resist. 7, 41 (2024).","journal-title":"Cancer Drug Resist."},{"key":"68509_CR42","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli, C., Chio, I. I. C. & Tuveson, D. A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 29, 1727\u20131745 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"68509_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36630-w","volume":"14","author":"PS Upadhyayula","year":"2023","unstructured":"Upadhyayula, P. S. et al. Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nat. Commun. 14, 1187 (2023).","journal-title":"Nat. Commun."},{"key":"68509_CR44","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang, D. et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186, 2748\u20132764.e2722 (2023).","journal-title":"Cell"},{"key":"68509_CR45","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol. Cell 83, 4352\u20134369.e4358 (2023).","journal-title":"Mol. Cell"},{"key":"68509_CR46","doi-asserted-by":"crossref","first-page":"147749","DOI":"10.1016\/j.gene.2023.147749","volume":"888","author":"P Gupta","year":"2023","unstructured":"Gupta, P. & Kumar, R. GTP cyclohydroxylase1 (GCH1): role in neurodegenerative diseases. Gene 888, 147749 (2023).","journal-title":"Gene"},{"key":"68509_CR47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/01.RES.0000153669.24827.DF","volume":"96","author":"AN Huang","year":"2005","unstructured":"Huang, A. N., Zhang, Y. Y., Chen, K., Hatakeyama, K. & Keaney, J. F. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-\u03baB and Stat1\/Stat3. Circ. Res. 96, 164\u2013171 (2005).","journal-title":"Circ. Res."},{"key":"68509_CR48","doi-asserted-by":"crossref","first-page":"21091","DOI":"10.1074\/jbc.273.33.21091","volume":"273","author":"L Xie","year":"1998","unstructured":"Xie, L., Smith, J. A. & Gross, S. S. GTP cyclohydrolase I inhibition by the prototypic inhibitor 2, 4-diamino-6-hydroxypyrimidine. Mechanisms and unanticipated role of GTP cyclohydrolase I feedback regulatory protein. J. Biol. Chem. 273, 21091\u201321098 (1998).","journal-title":"J. Biol. Chem."},{"key":"68509_CR49","doi-asserted-by":"crossref","unstructured":"Wei, J. L. et al. GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. J. Immunother. Cancer 9, e002383 (2021).","DOI":"10.1136\/jitc-2021-002383"},{"key":"68509_CR50","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"68509_CR51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"68509_CR52","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani, A. et al. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Res. 81, 1583\u20131594 (2021).","journal-title":"Cancer Res."},{"key":"68509_CR53","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas, D. & Majeti, R. Biology and relevance of human acute myeloid leukemia stem cells. Blood 129, 1577\u20131585 (2017).","journal-title":"Blood"},{"key":"68509_CR54","doi-asserted-by":"crossref","unstructured":"Lee, J. & Roh, J. L. Epigenetic modulation of ferroptosis in cancer: identifying epigenetic targets for novel anticancer therapy. Cell Oncol. 46, 1605\u20131623 (2023).","DOI":"10.1007\/s13402-023-00840-7"},{"key":"68509_CR55","doi-asserted-by":"crossref","unstructured":"Wu, Y. Q. et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol. Cancer 19, 39 (2020).","DOI":"10.1186\/s12943-020-01157-x"},{"key":"68509_CR56","doi-asserted-by":"crossref","unstructured":"Pei, Y. Z., Qian, Y. J., Wang, H. & Tan, L. Epigenetic regulation of ferroptosis-associated genes and its implication in cancer therapy. Front. Oncol. 12, 771870 (2022).","DOI":"10.3389\/fonc.2022.771870"},{"key":"68509_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng, S. et al. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp. Hematol. Oncol. 13, 19 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"68509_CR58","volume":"7","author":"W Li","year":"2021","unstructured":"Li, W., Li, W., Wang, Y., Leng, Y. & Xia, Z. Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia\/reperfusion injury. Cell Death Discov. 7, 267 (2021).","journal-title":"Cell Death Discov."},{"key":"68509_CR59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41413-024-00365-1","volume":"12","author":"B Ruan","year":"2024","unstructured":"Ruan, B. et al. DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis. Bone Res. 12, 68 (2024).","journal-title":"Bone Res."},{"key":"68509_CR60","volume":"4","author":"M Yang","year":"2023","unstructured":"Yang, M., Luo, H., Yi, X., Wei, X. & Jiang, D. S. The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. MedComm 4, e267 (2023).","journal-title":"MedComm"},{"key":"68509_CR61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","volume":"30","author":"SC Lu","year":"2009","unstructured":"Lu, S. C. Regulation of glutathione synthesis. Mol. Asp. Med. 30, 42\u201359 (2009).","journal-title":"Mol. Asp. Med."},{"key":"68509_CR62","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat. Commun. 14, 4193 (2023).","journal-title":"Nat. Commun."},{"key":"68509_CR63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold, I. et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172, 409\u2013422.e421 (2018).","journal-title":"Cell"},{"key":"68509_CR64","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","volume":"177","author":"I Alim","year":"2019","unstructured":"Alim, I. et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177, 1262\u20131279.e1225 (2019).","journal-title":"Cell"},{"key":"68509_CR65","volume":"2020","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. Responsive trimodal probes for in vivo imaging of liver inflammation by coassembly and GSH-driven disassembly. Research 2020, 4087069 (2020).","journal-title":"Research"},{"key":"68509_CR66","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"68509_CR67","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov, A. A. et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 16, 278\u2013290 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"68509_CR68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00726-008-0202-y","volume":"37","author":"MH Stipanuk","year":"2009","unstructured":"Stipanuk, M. H., Ueki, I., Dominy, J. E., Simmons, C. R. & Hirschberger, L. L. Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels. Amino Acids 37, 55\u201363 (2009).","journal-title":"Amino Acids"},{"key":"68509_CR69","doi-asserted-by":"crossref","first-page":"733751","DOI":"10.3389\/fcell.2021.733751","volume":"9","author":"S Wu","year":"2021","unstructured":"Wu, S., Li, T., Liu, W. & Huang, Y. Ferroptosis and cancer: complex relationship and potential application of exosomes. Front. Cell Dev. Biol. 9, 733751 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"68509_CR70","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21, 47 (2022).","journal-title":"Mol. Cancer"},{"key":"68509_CR71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell 186, 732\u2013747.e716 (2023).","journal-title":"Cell"},{"key":"68509_CR72","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s10571-023-01343-7","volume":"43","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Ferroptosis and neurodegenerative diseases: insights into the regulatory roles of SLC7A11. Cell Mol. Neurobiol. 43, 2627\u20132642 (2023).","journal-title":"Cell Mol. Neurobiol."},{"key":"68509_CR73","volume":"38","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2. Cell Rep. 38, 110253 (2022).","journal-title":"Cell Rep."},{"key":"68509_CR74","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-15-2949","volume":"76","author":"X Jiang","year":"2016","unstructured":"Jiang, X. et al. Eradication of acute myeloid leukemia with FLT3 ligand-targeted miR-150 Nanoparticles. Cancer Res. 76, 4470\u20134480 (2016).","journal-title":"Cancer Res."},{"key":"68509_CR75","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","volume":"22","author":"X Jiang","year":"2012","unstructured":"Jiang, X. et al. Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia. Cancer cell 22, 524\u2013535 (2012).","journal-title":"Cancer cell"},{"key":"68509_CR76","doi-asserted-by":"crossref","first-page":"101559","DOI":"10.1016\/j.xpro.2022.101559","volume":"3","author":"J Lu","year":"2022","unstructured":"Lu, J., Zhao, H., Yang, L. & Jiang, X. Protocol to establish a stable MLL-AF9_AML mouse model. STAR Protoc. 3, 101559 (2022).","journal-title":"STAR Protoc."},{"key":"68509_CR77","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1016\/j.molcel.2022.09.009","volume":"82","author":"K Jacobs","year":"2022","unstructured":"Jacobs, K. et al. Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming. Mol. Cell 82, 4176\u20134188.e4178 (2022).","journal-title":"Mol. Cell"},{"key":"68509_CR78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2016.06.028","volume":"63","author":"D Han","year":"2016","unstructured":"Han, D. et al. A highly sensitive and robust method for genome-wide 5hmC profiling of rare cell populations. Mol. Cell 63, 711\u2013719 (2016).","journal-title":"Mol. Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:02:30Z","timestamp":1771426950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68509"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68509-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1800"}}